SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
海洋之心
Lv5
2
820 积分
2021-03-16 加入
最近求助
最近应助
互助留言
Entrectinib-induced pericarditis with cardiac tamponade in a patient with neurotrophic tropomyosin receptor kinase 1 fusion-positive breast cancer
22小时前
求助中
Cancer genome profiling of prostate cancer identifies a patient with a novel EFNA1–NTRK1 fusion gene
1天前
求助中
Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis
3个月前
已关闭
Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system
3个月前
已关闭
Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis
3个月前
已完结
Osimertinib-Induced Lichenoid Drug Eruption: A Case Report
4个月前
已关闭
Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
4个月前
已完结
Comparative Safety of Ibrutinib Versus Zanubrutinib in Patients With Chronic Lymphocytic Leukemia: A Prospective Cohort Study
4个月前
已完结
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
4个月前
已完结
Real world outcomes with Ibrutinib monotherapy in Chronic Lymphocytic Leukemia: a single center experience
4个月前
已完结
没有进行任何应助
已经有了,谢!【积分已退回】
3个月前
已经有了,谢!【积分已退回】
3个月前
已经有了,谢【积分已退回】
3个月前
速度真快
3个月前
么么哒
4个月前
点赞
4个月前
感谢
4个月前
速度真快
4个月前
么么哒
4个月前
感谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论